FDA
approval
· 2019-05-10
FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
Summary
FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company, resulting in label/indication changes through the supplemental…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EPIVIR (LAMIVUDINE)